Becker's Healthcare May 7, 2024
Riz Hatton

Life sciences company Geneoscopy received FDA approval for its noninvasive colorectal cancer screening test, ColoSense.

ColoSense is the first noninvasive colorectal cancer screening test to offer a view of disease activity through RNA biomarkers, according...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Patient / Consumer, Pharma / Biotech, Provider
Cell and Gene Therapies — Improving Access and Outcomes for Medicare and Medicaid Beneficiaries
Americans split on using weight loss drugs to treat obesity: Survey
ASHP to CMS: 'Change course' on drug pricing
New AI model predicts gene expression across human cell types
Most Ditch GLP-1 Drugs for Weight Loss Within a Year

Share This Article